HR-2569-116
ASSUMING FIRST SPONSORSHIP - Mrs. Carolyn B. Maloney (NY) asked unanimous consent that she hereafter be considered as the first sponsor of H.R. 2569, a bill originally introduced by Representative Cummings, for the purpose of adding cosponsors and requesting reprintings pursuant to clause 7 of rule XII. Agreed to without objection.
What it does
This bill would create a new federal grant program under the Public Health Service Act to distribute emergency funding to states, territories, Tribal nations, cities, and counties disproportionately affected by the opioid epidemic. Grants would be allocated based on drug overdose death rates and non-fatal overdose data, with 10 percent of funds reserved for Tribal governments. The bill would also modify the Controlled Substances Act, fund Naloxone distribution, expand Medicaid treatment provider capacity, and direct additional appropriations to the NIH and CDC for substance use disorder research and surveillance.
Who benefits
Individuals with substance use disorders, particularly those in high-overdose counties, who would gain access to treatment, recovery housing, harm reduction services, and medication-assisted treatment. Low-income and uninsured individuals who would receive services regardless of ability to pay. Rural communities with limited treatment infrastructure. Tribal nations, which receive a dedicated 10% funding set-aside with flexible use rules. Incarcerated and formerly incarcerated individuals who could receive treatment in detention settings. LGBTQ individuals, historically underserved communities, and people experiencing homelessness, all of whom are explicitly included in planning council representation. Nonprofit treatment providers, federally qualified health centers, and rural health clinics that would receive direct financial assistance. Families of individuals with substance use disorders who would gain access to respite care and support services.
Who is hurt
Localities that do not meet the overdose-rate eligibility thresholds — including areas with emerging but not yet statistically severe crises — that would receive no formula grant funding. For-profit treatment providers, who may only receive funds if they are the sole available provider in an area. Medication-assisted treatment providers that do not also offer mental health services or referrals, who would be ineligible for funding. Taxpayers who would bear the cost of the new appropriations. States and localities that may face administrative burdens from planning council requirements, data reporting mandates, and maintenance-of-effort conditions. Competing federal health priorities that may face reduced attention or funding in the same budget cycle.
Supporters argue
Supporters argue that the opioid epidemic killed more than 47,000 Americans in 2018 alone and that existing federal programs are fragmented, underfunded, and too slow to reach the hardest-hit communities. They contend that the bill's data-driven eligibility formula — tied directly to overdose death rates and non-fatal overdose counts — ensures funds flow to areas of greatest demonstrated need rather than through political allocation. They further argue that the Ryan White HIV/AIDS Program, on which this bill is explicitly modeled, demonstrated that emergency, locally-administered grant programs can rapidly build treatment infrastructure and reduce mortality in communities overwhelmed by a public health crisis.
Opponents argue
Opponents argue that the bill creates a large, complex new federal bureaucracy — including mandatory planning councils, multi-layer eligibility criteria, maintenance-of-effort requirements, and binding arbitration procedures — that could slow the delivery of aid and impose significant administrative costs on already-strained local governments. They contend that the 15% administrative cap in year one and 10% in subsequent years may be insufficient for smaller jurisdictions to comply with reporting and oversight requirements, potentially diverting resources from direct services. They further argue that restricting for-profit providers and conditioning funding on mental health service integration may reduce the total supply of available treatment capacity in areas with few providers.